CLINICAL RESEARCH CONSULTING AGREEMENT (renewed)
Exhibit 4.4
CLINICAL RESEARCH CONSULTING AGREEMENT (renewed)
THIS CLITICAL RESEARCH AGREEMENT is made effective this 1st day of 2005 by and;
BETWEEN:
WOO-KYUNG SEO, 403-909, 4th Block, Xxxxxxx Xxxxxxx, Xxxxxxx-Xxxx, Xxxxx-Xx, Xxxxxx-Xxxx, Xxxxxxxx-Xx, Xxxxx (hereinafter referred to as “CONSULTANT”)
AND:
MERIDIAN CO., LTD., of 9Fl., Seoil Xxxx. 000, Xxxxxxxxx-xxxx, Xxxxxx-xx Xxxxx, Xxxxxxxx of Korea (hereinafter referred to as “MERIDIAN”)
WHEREAS:
A. MERIDIAN is engaged in the research, development, manufacturing and sales of medical devices mainly for the Oriental and Natural/Alternative Medicine;
B. CONSULTANT is a medical professional providing clinical research services in the North American regulatory standard; and
C. MERIDIAN considers it to be in its best interest to engage CONSULTANT to receive clinical research consulting services for its products in North America on the terms and subject to the conditions hereinafter set forth.
NOW THEREFORE THIS AGREEMENT WITNESS THAT the parties mutually agree as follows:
A. ENGAGEMENT
1.3 | Subject to the terms and conditions hereof, MERIDIAN
hereby engages CONSULTANT to receive the clinical research services set
out in Section 2 hereof (the “Services”). |
1.4 | CONSULTANT’s obligation to perform the Services
shall commence following the completion of the list of the Services, and
will continue from the Effective Date until terminated in accordance with
Article 4 hereof (the “Term”). |
B. SERVICES
2.1 | Conduct the medical research on every products of
MERIDIAN, which is acceptable in the US medical industry. |
2.2 | Prepare the appropriate research results for the
Meridian Products to meet the FDA standard. |
2.3 | Examine the products for FDA regulations (510(k)),
Pre-market Approval, Investigation Device Exemption. |
C. CONSIDERATION
3.1 | In consideration for the Services, MERIDIAN shall
pay CONSULTANT 62,400,000 Korean Won (equivalent to $62,400 US) or
number of the MERIDIAN’s common shares equivalent to the value of
$62,400 US ($0.20 US per share). |
D. EXPENSES AND COSTS
4.1 | All expenses related the Services shall be included in the payment set out in Section 3. |
E. TERMINATION AND RENEWAL
5.1 | This agreement may be terminated by MERIDIAN upon
the occurrence of any default by CONSULTANT by giving written notice to
CONSULTANT by giving written notice to CONSULTANT specifying the nature
of the default. A default will be defined as the occurrence of any one
ore more of the following: |
i. | CONSULTANT fails to perform any of the Services
in the manner or within the time required herein or commits or permits
a breach of or default in any of CONSULTANT’s covenants, duties
or obligations hereunder; or |
|
ii. | MERIDIAN acting reasonably determines that CONSULTANT
or any of its principals, directors, officers, agents or employees has
acted, is acting or is likely to act in a manner detrimental to MERIDIAN
or has violated the confidentiality of any information as provided for
in this agreement. |
F. CONFIDENTIALITY
6.1 | All reports, documents, concepts and products together
with any business contracts or any business opportunities prepared, produced,
developed or acquired by CONSULTANT, directly or indirectly, in connection
with CONSULTANT performing the Services (collectively, the “Work
Product”) will belong exclusively to MERIDIAN which will be entitled
to all rights, interest, profits or benefits in respect thereof. |
6.2 | No copies, summaries or other reproductions of any
Work Product shall be made by CONSULTANT without the express permission
of MERIDIAN, provided that CONSULTANT is given permission to maintain
one copy of the Work Product for its own use. |
6.3 | CONSULTANT will not disclose any information, documents
or Work Product which is developed by CONSULTANT or to which CONSULTANT
may have access by virtue of its performance of the Services to any person
not expressly authorized by MERIDIAN for that purpose. CONSULTANT will
comply with such directions as MERIDIAN may make to ensure the safeguarding
or confidentiality of all such information, documents and Work Product.
|
G. LAW
7.1 | This agreement shall be governed by and construed in accordance with the laws of the Republic of Korea and the parties hereby irrevocably attorney to the courts of such country. |
IN WITNESS THEREOF, the parties above have caused this Agreement to be duly executed, as of the day and year set out below.
WOO-KYUNG SEO | |
_____________________________ | ______________ |
Date | |
MERIDIAN CO., LTD., | |
By: _____________________________ | _____________ |
Xxxxx Xxxxx Xxxxxx, CEO/President | Date |